357 related articles for article (PubMed ID: 24738991)
41. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
[TBL] [Abstract][Full Text] [Related]
42. Acute CO poisoning is associated with impaired fibrinolysis and increased thrombin generation.
Gawlikowski T; Gomolka E; Piekoszewski W; Jawień W; Undas A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):352-6. PubMed ID: 23228150
[TBL] [Abstract][Full Text] [Related]
43. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
[TBL] [Abstract][Full Text] [Related]
44. Altered plasma fibrin clot properties are associated with in-stent thrombosis.
Undas A; Zalewski J; Krochin M; Siudak Z; Sadowski M; Pregowski J; Dudek D; Janion M; Witkowski A; Zmudka K
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):276-82. PubMed ID: 19910643
[TBL] [Abstract][Full Text] [Related]
45. The effect of chronic kidney disease on fibrin clot properties in patients with acute coronary syndrome.
Undas A; Nycz K; Pastuszczak M; Stompor T; Zmudka K
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):522-7. PubMed ID: 20479639
[TBL] [Abstract][Full Text] [Related]
46. Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age.
Jaworska-Wilczyńska M; Natorska J; Siudut J; Marzec K; Kowalik I; Hryniewiecki T; Undas A
Kardiol Pol; 2021; 79(7-8):796-803. PubMed ID: 34002842
[TBL] [Abstract][Full Text] [Related]
47. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
[TBL] [Abstract][Full Text] [Related]
48. Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform.
Undas A; Cieśla-Dul M; Drążkiewicz T; Sadowski J
Thromb Res; 2012 Sep; 130(3):e184-7. PubMed ID: 22762941
[TBL] [Abstract][Full Text] [Related]
49. Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome.
Celinska-Löwenhoff M; Zabczyk M; Iwaniec T; Plens K; Musial J; Undas A
Rheumatology (Oxford); 2018 Aug; 57(8):1340-1349. PubMed ID: 29672756
[TBL] [Abstract][Full Text] [Related]
50. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
[TBL] [Abstract][Full Text] [Related]
51. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
[TBL] [Abstract][Full Text] [Related]
52. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
Undas A; Slowik A; Wolkow P; Szczudlik A; Tracz W
Thromb Res; 2010 Apr; 125(4):357-61. PubMed ID: 19942259
[TBL] [Abstract][Full Text] [Related]
53. Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
Ząbczyk M; Kruk A; Natorska J; Undas A
Thromb Res; 2023 Dec; 232():70-76. PubMed ID: 37949000
[TBL] [Abstract][Full Text] [Related]
54. High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals.
Ząbczyk M; Hońdo Ł; Krzek M; Undas A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):50-4. PubMed ID: 23037322
[TBL] [Abstract][Full Text] [Related]
55. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
Mrozińska S; Cieślik J; Broniatowska E; Undas A
Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
[TBL] [Abstract][Full Text] [Related]
56. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
57. Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
Tehrani S; Jörneskog G; Ågren A; Lins PE; Wallén H; Antovic A
Thromb Haemost; 2015 Feb; 113(2):312-8. PubMed ID: 25318636
[TBL] [Abstract][Full Text] [Related]
58. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
59. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
[TBL] [Abstract][Full Text] [Related]
60. Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.
Stępień K; Ząbczyk M; Kopytek M; Natorska J; Zalewski J; Undas A
J Thromb Thrombolysis; 2024 Feb; 57(2):248-259. PubMed ID: 37932588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]